SIMVIS is a 50/50 Joint Venture between Gerolymatos International SA and Galenica SA that leverages on the long-standing pharmaceutical heritage of both partners. Simvis is focused on providing high quality 3rd Party Pharmaceutical Manufacturing services to Greek and foreign companies. Owning, promoting and marketing pharmaceutical products is outside the scope of SIMVIS, thus ensuring that there is no conflict of interest wit...
SIMVIS is a 50/50 Joint Venture between Gerolymatos International SA and Galenica SA that leverages on the long-standing pharmaceutical heritage of both partners. Simvis is focused on providing high quality 3rd Party Pharmaceutical Manufacturing services to Greek and foreign companies. Owning, promoting and marketing pharmaceutical products is outside the scope of SIMVIS, thus ensuring that there is no conflict of interest with customers that opt to entrust their production to SIMVIS.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.